Document is current
Any future updates will be listed below
-
Authors
Berentschot, J. C. https://orcid.org/0000-0003-4640-9947
Bek, L. M.
Heijenbrok-Kal, M. H.
van Bommel, J.
Ribbers, G. M.
Aerts, J. G. J. V.
Hellemons, M. E.
van den Berg-Emons, H. J. G.
,
Aerts, Joachim G. J. V.
Bek, L. Martine
Berentschot, Julia C.
van den Berg-Emons, Rita J. G.
Bindraban, Sieshem
Blox, Wouter J. B.
van Bommel, Jasper
Gajadin, Shai A.
van Genderen, Michel E.
Gommers, Diederik A. M. P. J.
Heijenbrok-Kal, Majanka H.
Hellemons, Merel E.
Heller, Roxane
Ista, Erwin
van Loon-Kooij, Stephanie
Luijkx, Chantal
Osterthun, Rutger
Oswald, Laurien
Ribbers, Gerard M.
van Rossem, Ronald N.
van de Sande, Herbert J.
van der Stoep, Robert
Tazmi-Staal, Janette J.
Wijffels, Markus P. J. M.
Willems, Eva G.
-
Funding
Funding for this research was provided by:
ZonMw (10430022010026)
Rijndam revalidatie
Laurens
- License Information
-
More Information
Article History
Received: 30 May 2024
Accepted: 28 August 2024
First Online: 8 November 2024
Declarations
:
: The COvid-19 Follow-up care paths and Long-term Outcomes Within the Dutch healthcare system (CO-FLOW) study with trial register no. NL8710 (registered on the WHO ICTRP) was approved by the Medical Ethics Committee of the Erasmus MC, University Medical Center Rotterdam (MEC-2020-0487). All participants provided informed consent before data collection.
: Not applicable.
: The authors declare that they have no competing interests related to this paper.
